Jinyun Chen

Title: Jinyun Chen: Innovator in Viral Infection Prevention

Introduction

Jinyun Chen is a notable inventor based in Emeryville, CA (US). He has made significant contributions to the field of viral infection prevention, particularly through his innovative chimeric protein technologies. With a total of 2 patents, Chen's work focuses on developing solutions to combat influenza and coronavirus infections.

Latest Patents

Chen's latest patents include a chimeric protein that comprises an anti-influenza virus antibody moiety and a mucoadhesive peptide fragment. This invention aims to prevent or treat influenza infections by utilizing proteins that specifically bind to components of the influenza virus. Additionally, he has developed compositions for preventing or treating coronavirus infections. This patent involves chimeric proteins that include an extracellular binding domain of an angiotensin-converting enzyme 2 (ACE2) protein, which targets the S protein of the virus.

Career Highlights

Jinyun Chen is currently associated with Invisishield Technologies Ltd., where he continues to advance his research and development efforts. His work is pivotal in creating effective treatments for viral infections, showcasing his commitment to public health and safety.

Collaborations

Chen collaborates with Ziyou Cui, who is also a key figure in his research endeavors. Their partnership enhances the innovative potential of their projects and contributes to the advancement of their shared goals in viral infection prevention.

Conclusion

Jinyun Chen's contributions to the field of viral infection prevention through his innovative patents highlight his role as a leading inventor. His work not only addresses current health challenges but also paves the way for future advancements in medical technology.